CANF · Can-Fite BioPharma Ltd. · Documents
Market Cap
$5.73M
Shares
3.03M
Volume · Oct 21
11.17K
Avg daily vol (3M)
358.4K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2022-10-25 | — | |
| 6-K | — | 2022-09-12 | — | |
| 6-K | — | 2022-09-07 | — | |
| 6-K | — | 2022-08-29 | — | |
| 6-K | — | 2022-08-25 | 2022-06-30 | |
| 6-K | — | 2022-08-23 | — | |
| 6-K | — | 2022-08-22 | — | |
| 6-K | — | 2022-08-17 | — | |
| 6-K | — | 2022-07-25 | — | |
| 6-K | — | 2022-07-11 | — | |
| 6-K | — | 2022-06-29 | — | |
| 6-K | — | 2022-06-24 | — | |
| 6-K | — | 2022-06-09 | — | |
| 6-K | — | 2022-05-26 | — | |
| 6-K | — | 2022-05-16 | — | |
| 6-K | — | 2022-05-02 | — | |
| 6-K | — | 2022-04-05 | — | |
| 6-K | — | 2022-03-24 | — | |
| 20-F | — | 2022-03-24 | 2021-12-31 | |
| 6-K | — | 2022-03-14 | — | |
| 6-K | — | 2022-03-11 | — | |
| 6-K | — | 2022-03-08 | — | |
| 6-K | — | 2022-01-31 | — | |
| 6-K | — | 2022-01-13 | — | |
| 6-K | — | 2022-01-05 | — | |
| 6-K | — | 2021-12-29 | — | |
| 6-K | — | 2021-12-23 | — | |
| 6-K | — | 2021-12-20 | — | |
| 6-K | — | 2021-12-20 | — | |
| 6-K | — | 2021-12-07 | — | |
| 6-K | — | 2021-11-26 | — | |
| 6-K | — | 2021-11-23 | — | |
| 6-K | — | 2021-10-28 | — | |
| 6-K | — | 2021-10-21 | — | |
| 6-K | — | 2021-09-02 | — | |
| 6-K | — | 2021-08-26 | 2021-06-30 | |
| 6-K | — | 2021-08-16 | — | |
| 6-K | — | 2021-08-12 | — | |
| 6-K | — | 2021-08-05 | — | |
| 6-K | — | 2021-07-29 | — | |
| 6-K | — | 2021-07-08 | — | |
| 6-K | — | 2021-06-28 | — | |
| 6-K | — | 2021-06-23 | 2021-06-22 | |
| 6-K | — | 2021-06-16 | — | |
| 6-K | — | 2021-06-14 | — | |
| 6-K | — | 2021-06-07 | — | |
| 6-K | — | 2021-06-02 | — | |
| 6-K | — | 2021-06-01 | — | |
| 6-K | — | 2021-05-27 | — | |
| 6-K | — | 2021-04-29 | — |
Showing 151–200 of 279 filings